Artificial Intelligence for Drug Product Lifecycle Applications

Description

English | 2025 | PDF | 8 MB | 284 Pages

Alberto Pais, Carla Vitorino, Sandra Nunes, Tânia Cova, B0DGCYRGPY, 0323918190, 0323972519, 9780323972512, 978-0323972512, 9780323918190, 978-0323918190, 978-0-323-91819-0
Artificial Intelligence for Drug Product Lifecycle Applications explains the use of artificial intelligence (AI) in drug discovery and development paths, including the clinical and postapproval phases. This book gives methods for each of the drug development steps, from the fundamentals to postapproval drug product. AI is a synergistic assembly of enhanced optimization strategies with particular applications in pharmaceutical development and advanced tools for promoting cost-effectiveness throughout the drug lifecycle. Specifically, AI brings together the potential to improve drug approval rates, reduce development costs, get medications to patients faster, and help patients comply with their treatments.Accelerated pharmaceutical development and drug product approval rates will enable larger profits from patent-protected market exclusivity. This book offers the tools and knowledge to create the right AI strategy to extend the landscape of AI applications across the drug lifecycle. It is especially useful for pharmaceutical scientists, health care professionals, and regulatory scientists, as well as advanced students and postgraduates actively involved in pharmaceutical product and process development involving the use of artificial intelligence in drug delivery applications.
– Classifies AI methodologies and application examples into different categories representing the various steps of the drug development cycle
– Combines timely literature review with clear artworks to improve understanding
– Examines deep learning and machine learning in drug discovery